Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Pal S, Graves H, Ohsawa R, Huang T-, Wang P, Harmacek L, et al. The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells. PLoS One. 2016;11(5):e0155409.

Onur I, Siddiqui MT, Wakely PE, Ali SZ. Pseudomyxoma peritonei: cytomorphologic findings and clinicopathologic correlates. J Am Soc Cytopathol. 2016;5(1):43-49.

Inayat F, Law JK, Myers-Gurevitch PM, Seshan SV, Perlman AS. Minimal change disease: an unusual presentation of marginal zone MALT lymphoma. Clin Nephrol. 2016;85(3):184-8.

Pizzi M, Covey S, Mathew S, Liu Y-, Ruan J, Leonard JP, et al. Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2016;16(3):e47-50.

Welsh KJ, Hermane AT, Zhao Z. Is This Patient Pregnant? Clin Chem. 2016;62(8):1163-4.

Shanmugam V, Geraghty B, DeSimone RA, Hoda RS. Diagnostic value of positive urinary cytology in the detection of recurrent urothelial carcinoma: 10-Year Experience at the Papanicolaou Cytology Laboratory. Diagn Cytopathol. 2016;44(12):975-979.

Pan J-, Sun Y, Jiang Y-, Bott AJ, Jaber N, Dou Z, et al. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. Mol Cell. 2016;61(5):720-733.

Kahlert UD, Cheng M, Koch K, Marchionni L, Fan X, Raabe EH, et al. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. Int J Cancer. 2016;138(5):1246-55.

Davis JE, Nemesure B, Mehmood S, Nayi V, Burke S, Brzostek SR, et al. Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ. Appl Immunohistochem Mol Morphol. 2016;24(1):20-5.

Moscat J, Karin M, Diaz-Meco MT. p62 in Cancer: Signaling Adaptor Beyond Autophagy. Cell. 2016;167(3):606-609.